(Q53171288)

12 May 2018

title

Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer. (English)

1 reference

12 May 2018

Niklaus G Schaefer

12

0 references

Burkhardt Seifert

object named as

Burkhardt Seifert

4

0 references

author name string

Jan D Soyka

1

1 reference

12 May 2018

Marco A Muster

2

1 reference

12 May 2018

Daniel T Schmid

3

1 reference

12 May 2018

Ulrike Schick

5

1 reference

12 May 2018

Raymond Miralbell

6

1 reference

12 May 2018

Sandra Jorcano

7

1 reference

12 May 2018

Kathrin Zaugg

8

1 reference

12 May 2018

Hans-Helge Seifert

9

1 reference

12 May 2018

Patrick Veit-Haibach

10

1 reference

12 May 2018

Klaus Strobel

11

1 reference

12 May 2018

Daniela B Husarik

13

1 reference

12 May 2018

Thomas F Hany

14

1 reference

12 May 2018

publication date

14 March 2012

1 reference

12 May 2018

number of pages

8

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

12 May 2018

volume

39

1 reference

12 May 2018

issue

6

1 reference

12 May 2018

page(s)

936-943

1 reference

12 May 2018

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2083-2

Management of recurrent disease after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2083-2

Patient-re ported complications and follow-up treatment after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2083-2

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2083-2

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2083-2

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2083-2

Fluorocholine PET/CT in patients with prostate cancer: initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2083-2

The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2083-2

Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2083-2

The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2083-2

Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2083-2

Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA < 5 ng/ml?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2083-2

Is there a role for ¹¹C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2083-2

[18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2083-2

Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2083-2

Re: Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al. EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer. Eur Urol 2011;59:572–83

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2083-2

Follow-up prostate cancer treatments after radical prostatectomy: a population-based study

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22415598

12 December 2020

inferred from PubMed ID database lookup

Influence of 11C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22415598

12 December 2020

inferred from PubMed ID database lookup

Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22415598

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00259-012-2083-2

1 reference

12 May 2018

release_bwod4k56bnfshdfeddlcmntv7e

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bwod4k56bnfshdfeddlcmntv7e

24 November 2022

mapped directly with Wikidata item

1 reference

12 May 2018